LFMD
Get informed when a big investor buys or sells
+ Follow| Market cap | $169.27 Million |
|---|---|
| Enterprise Value | $152.98 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.23 |
| Beta | 1.99 |
| Outstanding Shares | 47,336,060 |
| P/E Ratio | -8.49 |
|---|---|
| PEG | 1.07 |
| Price to Sales | 1.3 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.92 |
| Enterprise Value to EBIT | -7.99 |
| Enterprise Value to Net Income | 41 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 1.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 67.65% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 1.42%▼ 36.26% |
|---|---|
| Total Invested | $2.78M▼ 95.68% |
| Investors Holding | 20▼ 87.00% |
No data
LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordab...